Leading Medical Journal Prints Article on Avandia Drug Side Effects
On June 5, 2007, the New England Journal of Medicine responded to a
medical study that sought to put to rest the fear that the Type 2 diabetes drug
Avandia had serious heart-related side effects. The journal's authors found that
the study did not alleviate the concern that the medicine raised the risk of a
heart attack or death from cardiovascular disease in users.
In the
article "Rosiglitazone--Continued Uncertainty about Safety," authors Jeffrey M.
Drazen, M.D., Stephen Morrissey, Ph.D. and Gregory D. Curfman, M.D. conclude
that "there is continued uncertainty about the cardiovascular safety of
rosiglitazone [[brand name Avandia]]."
The authors additionally caution
about the seriousness of deeming a drug safe for public consumption without
fully assessing the research: "In this age of freely available information,
drugs cannot easily be parsed into 'safe' and 'unsafe'
categories."
Instead, they say, there will be shades of safety that must
be graded against the shades of efficacy.
If you or a loved one has
suffered cardiac complications after ingesting Avandia, you deserve the guidance
of an experienced drug attorney. Get a free case review by filling out the form
below.
see also:
Dallas Lawsuit
Avandia Lawsuit Filed in Dallas Federal Court Against GlaxoSmithKlineDallas Man Dies of Heart Attack the Day News Breaks of Avandia Risks
Experts Cite Risks
Federal Scientist: Pull Avandia From the Market Because of Heart RisksPanel Convenes, Scientist Recommends Taking Avandia off the Market
News & Warnings
Avandia Breaking News: Glaxo Warned in 2001 about Misleading MarketingBloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001
